Pazopanib Hydrochloride in Treating Patients With Progressive Carcinoid Tumors
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Centre Oscar Lambret
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
University of California, San Francisco
Hoffmann-La Roche
Columbia University
Olivia Newton-John Cancer Research Institute
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Tata Memorial Hospital
Institut du Cancer de Montpellier - Val d'Aurelle
Imperial College London
Imperial College London
Imperial College London
M.D. Anderson Cancer Center
Ohio State University Comprehensive Cancer Center
Washington University School of Medicine
Abramson Cancer Center at Penn Medicine
Fox Chase Cancer Center
University of Alberta
Crinetics Pharmaceuticals Inc.
Amgen
National Cancer Center, Korea
Merck Sharp & Dohme LLC
University of California, San Francisco
Australasian Gastro-Intestinal Trials Group
Hutchmed
University Hospital, Bordeaux
University of Iowa
University of Pittsburgh
Grupo Espanol de Tumores Neuroendocrinos
Erasmus Medical Center
Orano Med LLC
Instituto do Cancer do Estado de São Paulo
University of Alberta
Melanoma and Skin Cancer Trials Limited
EpicentRx, Inc.
Peking University
Clarity Pharmaceuticals Ltd
Latin American Cooperative Oncology Group
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
Grupo Espanol de Tumores Neuroendocrinos
Grupo Espanol de Tumores Neuroendocrinos
Beijing Chest Hospital
Abramson Cancer Center at Penn Medicine
Sunnybrook Health Sciences Centre
Biotheus Inc.